Table of Content

1 Viral Gastroenteritis Drugs Market Overview
1.1 Product Overview and Scope of Viral Gastroenteritis Drugs
1.2 Viral Gastroenteritis Drugs Segment by Type
1.2.1 Global Viral Gastroenteritis Drugs Market Value Comparison by Type (2024-2034)
1.2.2 Antibiotic
1.2.3 Antacids
1.2.4 Antikinetic Agent
1.2.5 Other
1.3 Viral Gastroenteritis Drugs Segment by Application
1.3.1 Global Viral Gastroenteritis Drugs Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Viral Gastroenteritis Drugs Market Size Estimates and Forecasts
1.4.1 Global Viral Gastroenteritis Drugs Revenue 2018-2029
1.4.2 Global Viral Gastroenteritis Drugs Sales 2018-2029
1.4.3 Global Viral Gastroenteritis Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Viral Gastroenteritis Drugs Market Competition by Manufacturers
2.1 Global Viral Gastroenteritis Drugs Sales Market Share by Manufacturers (2018-2024)
2.2 Global Viral Gastroenteritis Drugs Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Viral Gastroenteritis Drugs Average Price by Manufacturers (2018-2024)
2.4 Global Viral Gastroenteritis Drugs Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Viral Gastroenteritis Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Viral Gastroenteritis Drugs, Product Type & Application
2.7 Viral Gastroenteritis Drugs Market Competitive Situation and Trends
2.7.1 Viral Gastroenteritis Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Viral Gastroenteritis Drugs Players Market Share by Revenue
2.7.3 Global Viral Gastroenteritis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Viral Gastroenteritis Drugs Retrospective Market Scenario by Region
3.1 Global Viral Gastroenteritis Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Viral Gastroenteritis Drugs Global Viral Gastroenteritis Drugs Sales by Region: 2018-2029
3.2.1 Global Viral Gastroenteritis Drugs Sales by Region: 2018-2024
3.2.2 Global Viral Gastroenteritis Drugs Sales by Region: 2024-2029
3.3 Global Viral Gastroenteritis Drugs Global Viral Gastroenteritis Drugs Revenue by Region: 2018-2029
3.3.1 Global Viral Gastroenteritis Drugs Revenue by Region: 2018-2024
3.3.2 Global Viral Gastroenteritis Drugs Revenue by Region: 2024-2029
3.4 North America Viral Gastroenteritis Drugs Market Facts & Figures by Country
3.4.1 North America Viral Gastroenteritis Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Viral Gastroenteritis Drugs Sales by Country (2018-2029)
3.4.3 North America Viral Gastroenteritis Drugs Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Viral Gastroenteritis Drugs Market Facts & Figures by Country
3.5.1 Europe Viral Gastroenteritis Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Viral Gastroenteritis Drugs Sales by Country (2018-2029)
3.5.3 Europe Viral Gastroenteritis Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Viral Gastroenteritis Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Viral Gastroenteritis Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Viral Gastroenteritis Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Viral Gastroenteritis Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Viral Gastroenteritis Drugs Market Facts & Figures by Country
3.7.1 Latin America Viral Gastroenteritis Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Viral Gastroenteritis Drugs Sales by Country (2018-2029)
3.7.3 Latin America Viral Gastroenteritis Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Viral Gastroenteritis Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Viral Gastroenteritis Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Viral Gastroenteritis Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Viral Gastroenteritis Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Viral Gastroenteritis Drugs Sales by Type (2018-2029)
4.1.1 Global Viral Gastroenteritis Drugs Sales by Type (2018-2024)
4.1.2 Global Viral Gastroenteritis Drugs Sales by Type (2024-2029)
4.1.3 Global Viral Gastroenteritis Drugs Sales Market Share by Type (2018-2029)
4.2 Global Viral Gastroenteritis Drugs Revenue by Type (2018-2029)
4.2.1 Global Viral Gastroenteritis Drugs Revenue by Type (2018-2024)
4.2.2 Global Viral Gastroenteritis Drugs Revenue by Type (2024-2029)
4.2.3 Global Viral Gastroenteritis Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Viral Gastroenteritis Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global Viral Gastroenteritis Drugs Sales by Application (2018-2029)
5.1.1 Global Viral Gastroenteritis Drugs Sales by Application (2018-2024)
5.1.2 Global Viral Gastroenteritis Drugs Sales by Application (2024-2029)
5.1.3 Global Viral Gastroenteritis Drugs Sales Market Share by Application (2018-2029)
5.2 Global Viral Gastroenteritis Drugs Revenue by Application (2018-2029)
5.2.1 Global Viral Gastroenteritis Drugs Revenue by Application (2018-2024)
5.2.2 Global Viral Gastroenteritis Drugs Revenue by Application (2024-2029)
5.2.3 Global Viral Gastroenteritis Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Viral Gastroenteritis Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Pfizer Viral Gastroenteritis Drugs Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 AbbVie
6.2.1 AbbVie Corporation Information
6.2.2 AbbVie Description and Business Overview
6.2.3 AbbVie Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
6.2.4 AbbVie Viral Gastroenteritis Drugs Product Portfolio
6.2.5 AbbVie Recent Developments/Updates
6.3 Bayer AG
6.3.1 Bayer AG Corporation Information
6.3.2 Bayer AG Description and Business Overview
6.3.3 Bayer AG Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Bayer AG Viral Gastroenteritis Drugs Product Portfolio
6.3.5 Bayer AG Recent Developments/Updates
6.4 Sanofi S.A.
6.4.1 Sanofi S.A. Corporation Information
6.4.2 Sanofi S.A. Description and Business Overview
6.4.3 Sanofi S.A. Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Sanofi S.A. Viral Gastroenteritis Drugs Product Portfolio
6.4.5 Sanofi S.A. Recent Developments/Updates
6.5 AstraZeneca Plc.
6.5.1 AstraZeneca Plc. Corporation Information
6.5.2 AstraZeneca Plc. Description and Business Overview
6.5.3 AstraZeneca Plc. Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
6.5.4 AstraZeneca Plc. Viral Gastroenteritis Drugs Product Portfolio
6.5.5 AstraZeneca Plc. Recent Developments/Updates
6.6 Abbott Laboratories
6.6.1 Abbott Laboratories Corporation Information
6.6.2 Abbott Laboratories Description and Business Overview
6.6.3 Abbott Laboratories Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Abbott Laboratories Viral Gastroenteritis Drugs Product Portfolio
6.6.5 Abbott Laboratories Recent Developments/Updates
6.7 GlaxoSmithKline Plc.
6.6.1 GlaxoSmithKline Plc. Corporation Information
6.6.2 GlaxoSmithKline Plc. Description and Business Overview
6.6.3 GlaxoSmithKline Plc. Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
6.4.4 GlaxoSmithKline Plc. Viral Gastroenteritis Drugs Product Portfolio
6.7.5 GlaxoSmithKline Plc. Recent Developments/Updates
6.8 Takeda Pharmaceutical Company Limited
6.8.1 Takeda Pharmaceutical Company Limited Corporation Information
6.8.2 Takeda Pharmaceutical Company Limited Description and Business Overview
6.8.3 Takeda Pharmaceutical Company Limited Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Takeda Pharmaceutical Company Limited Viral Gastroenteritis Drugs Product Portfolio
6.8.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
6.9 EliLilly and Company
6.9.1 EliLilly and Company Corporation Information
6.9.2 EliLilly and Company Description and Business Overview
6.9.3 EliLilly and Company Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
6.9.4 EliLilly and Company Viral Gastroenteritis Drugs Product Portfolio
6.9.5 EliLilly and Company Recent Developments/Updates
6.10 Amgen Inc
6.10.1 Amgen Inc Corporation Information
6.10.2 Amgen Inc Description and Business Overview
6.10.3 Amgen Inc Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Amgen Inc Viral Gastroenteritis Drugs Product Portfolio
6.10.5 Amgen Inc Recent Developments/Updates
6.11 C.H.Boehringer Sohn AG & Co.KG
6.11.1 C.H.Boehringer Sohn AG & Co.KG Corporation Information
6.11.2 C.H.Boehringer Sohn AG & Co.KG Viral Gastroenteritis Drugs Description and Business Overview
6.11.3 C.H.Boehringer Sohn AG & Co.KG Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
6.11.4 C.H.Boehringer Sohn AG & Co.KG Viral Gastroenteritis Drugs Product Portfolio
6.11.5 C.H.Boehringer Sohn AG & Co.KG Recent Developments/Updates
6.12 Daiichi Sankyo Company Limited
6.12.1 Daiichi Sankyo Company Limited Corporation Information
6.12.2 Daiichi Sankyo Company Limited Viral Gastroenteritis Drugs Description and Business Overview
6.12.3 Daiichi Sankyo Company Limited Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Daiichi Sankyo Company Limited Viral Gastroenteritis Drugs Product Portfolio
6.12.5 Daiichi Sankyo Company Limited Recent Developments/Updates
6.13 Regeneron Pharmaceuticals lInc.
6.13.1 Regeneron Pharmaceuticals lInc. Corporation Information
6.13.2 Regeneron Pharmaceuticals lInc. Viral Gastroenteritis Drugs Description and Business Overview
6.13.3 Regeneron Pharmaceuticals lInc. Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Regeneron Pharmaceuticals lInc. Viral Gastroenteritis Drugs Product Portfolio
6.13.5 Regeneron Pharmaceuticals lInc. Recent Developments/Updates
6.14 Mylan N.V.
6.14.1 Mylan N.V. Corporation Information
6.14.2 Mylan N.V. Viral Gastroenteritis Drugs Description and Business Overview
6.14.3 Mylan N.V. Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Mylan N.V. Viral Gastroenteritis Drugs Product Portfolio
6.14.5 Mylan N.V. Recent Developments/Updates
6.15 Astellas Pharma Inc.
6.15.1 Astellas Pharma Inc. Corporation Information
6.15.2 Astellas Pharma Inc. Viral Gastroenteritis Drugs Description and Business Overview
6.15.3 Astellas Pharma Inc. Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Astellas Pharma Inc. Viral Gastroenteritis Drugs Product Portfolio
6.15.5 Astellas Pharma Inc. Recent Developments/Updates
6.16 Fresenius Kabi AG
6.16.1 Fresenius Kabi AG Corporation Information
6.16.2 Fresenius Kabi AG Viral Gastroenteritis Drugs Description and Business Overview
6.16.3 Fresenius Kabi AG Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Fresenius Kabi AG Viral Gastroenteritis Drugs Product Portfolio
6.16.5 Fresenius Kabi AG Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Viral Gastroenteritis Drugs Industry Chain Analysis
7.2 Viral Gastroenteritis Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Viral Gastroenteritis Drugs Production Mode & Process
7.4 Viral Gastroenteritis Drugs Sales and Marketing
7.4.1 Viral Gastroenteritis Drugs Sales Channels
7.4.2 Viral Gastroenteritis Drugs Distributors
7.5 Viral Gastroenteritis Drugs Customers
8 Viral Gastroenteritis Drugs Market Dynamics
8.1 Viral Gastroenteritis Drugs Industry Trends
8.2 Viral Gastroenteritis Drugs Market Drivers
8.3 Viral Gastroenteritis Drugs Market Challenges
8.4 Viral Gastroenteritis Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Viral Gastroenteritis Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Viral Gastroenteritis Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Viral Gastroenteritis Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Viral Gastroenteritis Drugs Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Viral Gastroenteritis Drugs Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Viral Gastroenteritis Drugs Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Viral Gastroenteritis Drugs Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Viral Gastroenteritis Drugs Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Viral Gastroenteritis Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Viral Gastroenteritis Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Viral Gastroenteritis Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Viral Gastroenteritis Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Viral Gastroenteritis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Gastroenteritis Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Viral Gastroenteritis Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Viral Gastroenteritis Drugs Sales by Region (2018-2024) & (K Units)
Table 18. Global Viral Gastroenteritis Drugs Sales Market Share by Region (2018-2024)
Table 19. Global Viral Gastroenteritis Drugs Sales by Region (2024-2029) & (K Units)
Table 20. Global Viral Gastroenteritis Drugs Sales Market Share by Region (2024-2029)
Table 21. Global Viral Gastroenteritis Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Viral Gastroenteritis Drugs Revenue Market Share by Region (2018-2024)
Table 23. Global Viral Gastroenteritis Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Viral Gastroenteritis Drugs Revenue Market Share by Region (2024-2029)
Table 25. North America Viral Gastroenteritis Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Viral Gastroenteritis Drugs Sales by Country (2018-2024) & (K Units)
Table 27. North America Viral Gastroenteritis Drugs Sales by Country (2024-2029) & (K Units)
Table 28. North America Viral Gastroenteritis Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Viral Gastroenteritis Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Viral Gastroenteritis Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Viral Gastroenteritis Drugs Sales by Country (2018-2024) & (K Units)
Table 32. Europe Viral Gastroenteritis Drugs Sales by Country (2024-2029) & (K Units)
Table 33. Europe Viral Gastroenteritis Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Viral Gastroenteritis Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Viral Gastroenteritis Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Viral Gastroenteritis Drugs Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Viral Gastroenteritis Drugs Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Viral Gastroenteritis Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Viral Gastroenteritis Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Viral Gastroenteritis Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Viral Gastroenteritis Drugs Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Viral Gastroenteritis Drugs Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Viral Gastroenteritis Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Viral Gastroenteritis Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Viral Gastroenteritis Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Viral Gastroenteritis Drugs Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Viral Gastroenteritis Drugs Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Viral Gastroenteritis Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Viral Gastroenteritis Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Viral Gastroenteritis Drugs Sales (K Units) by Type (2018-2024)
Table 51. Global Viral Gastroenteritis Drugs Sales (K Units) by Type (2024-2029)
Table 52. Global Viral Gastroenteritis Drugs Sales Market Share by Type (2018-2024)
Table 53. Global Viral Gastroenteritis Drugs Sales Market Share by Type (2024-2029)
Table 54. Global Viral Gastroenteritis Drugs Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Viral Gastroenteritis Drugs Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Viral Gastroenteritis Drugs Revenue Market Share by Type (2018-2024)
Table 57. Global Viral Gastroenteritis Drugs Revenue Market Share by Type (2024-2029)
Table 58. Global Viral Gastroenteritis Drugs Price (US$/Unit) by Type (2018-2024)
Table 59. Global Viral Gastroenteritis Drugs Price (US$/Unit) by Type (2024-2029)
Table 60. Global Viral Gastroenteritis Drugs Sales (K Units) by Application (2018-2024)
Table 61. Global Viral Gastroenteritis Drugs Sales (K Units) by Application (2024-2029)
Table 62. Global Viral Gastroenteritis Drugs Sales Market Share by Application (2018-2024)
Table 63. Global Viral Gastroenteritis Drugs Sales Market Share by Application (2024-2029)
Table 64. Global Viral Gastroenteritis Drugs Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Viral Gastroenteritis Drugs Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Viral Gastroenteritis Drugs Revenue Market Share by Application (2018-2024)
Table 67. Global Viral Gastroenteritis Drugs Revenue Market Share by Application (2024-2029)
Table 68. Global Viral Gastroenteritis Drugs Price (US$/Unit) by Application (2018-2024)
Table 69. Global Viral Gastroenteritis Drugs Price (US$/Unit) by Application (2024-2029)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Pfizer Viral Gastroenteritis Drugs Product
Table 74. Pfizer Recent Developments/Updates
Table 75. AbbVie Corporation Information
Table 76. AbbVie Description and Business Overview
Table 77. AbbVie Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. AbbVie Viral Gastroenteritis Drugs Product
Table 79. AbbVie Recent Developments/Updates
Table 80. Bayer AG Corporation Information
Table 81. Bayer AG Description and Business Overview
Table 82. Bayer AG Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Bayer AG Viral Gastroenteritis Drugs Product
Table 84. Bayer AG Recent Developments/Updates
Table 85. Sanofi S.A. Corporation Information
Table 86. Sanofi S.A. Description and Business Overview
Table 87. Sanofi S.A. Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Sanofi S.A. Viral Gastroenteritis Drugs Product
Table 89. Sanofi S.A. Recent Developments/Updates
Table 90. AstraZeneca Plc. Corporation Information
Table 91. AstraZeneca Plc. Description and Business Overview
Table 92. AstraZeneca Plc. Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. AstraZeneca Plc. Viral Gastroenteritis Drugs Product
Table 94. AstraZeneca Plc. Recent Developments/Updates
Table 95. Abbott Laboratories Corporation Information
Table 96. Abbott Laboratories Description and Business Overview
Table 97. Abbott Laboratories Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Abbott Laboratories Viral Gastroenteritis Drugs Product
Table 99. Abbott Laboratories Recent Developments/Updates
Table 100. GlaxoSmithKline Plc. Corporation Information
Table 101. GlaxoSmithKline Plc. Description and Business Overview
Table 102. GlaxoSmithKline Plc. Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. GlaxoSmithKline Plc. Viral Gastroenteritis Drugs Product
Table 104. GlaxoSmithKline Plc. Recent Developments/Updates
Table 105. Takeda Pharmaceutical Company Limited Corporation Information
Table 106. Takeda Pharmaceutical Company Limited Description and Business Overview
Table 107. Takeda Pharmaceutical Company Limited Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Takeda Pharmaceutical Company Limited Viral Gastroenteritis Drugs Product
Table 109. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 110. EliLilly and Company Corporation Information
Table 111. EliLilly and Company Description and Business Overview
Table 112. EliLilly and Company Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. EliLilly and Company Viral Gastroenteritis Drugs Product
Table 114. EliLilly and Company Recent Developments/Updates
Table 115. Amgen Inc Corporation Information
Table 116. Amgen Inc Description and Business Overview
Table 117. Amgen Inc Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Amgen Inc Viral Gastroenteritis Drugs Product
Table 119. Amgen Inc Recent Developments/Updates
Table 120. C.H.Boehringer Sohn AG & Co.KG Corporation Information
Table 121. C.H.Boehringer Sohn AG & Co.KG Description and Business Overview
Table 122. C.H.Boehringer Sohn AG & Co.KG Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. C.H.Boehringer Sohn AG & Co.KG Viral Gastroenteritis Drugs Product
Table 124. C.H.Boehringer Sohn AG & Co.KG Recent Developments/Updates
Table 125. Daiichi Sankyo Company Limited Corporation Information
Table 126. Daiichi Sankyo Company Limited Description and Business Overview
Table 127. Daiichi Sankyo Company Limited Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Daiichi Sankyo Company Limited Viral Gastroenteritis Drugs Product
Table 129. Daiichi Sankyo Company Limited Recent Developments/Updates
Table 130. Regeneron Pharmaceuticals lInc. Corporation Information
Table 131. Regeneron Pharmaceuticals lInc. Description and Business Overview
Table 132. Regeneron Pharmaceuticals lInc. Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Regeneron Pharmaceuticals lInc. Viral Gastroenteritis Drugs Product
Table 134. Regeneron Pharmaceuticals lInc. Recent Developments/Updates
Table 135. Mylan N.V. Corporation Information
Table 136. Mylan N.V. Description and Business Overview
Table 137. Mylan N.V. Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Mylan N.V. Viral Gastroenteritis Drugs Product
Table 139. Mylan N.V. Recent Developments/Updates
Table 140. Astellas Pharma Inc. Corporation Information
Table 141. Astellas Pharma Inc. Description and Business Overview
Table 142. Astellas Pharma Inc. Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Astellas Pharma Inc. Viral Gastroenteritis Drugs Product
Table 144. Astellas Pharma Inc. Recent Developments/Updates
Table 145. Fresenius Kabi AG Corporation Information
Table 146. Fresenius Kabi AG Description and Business Overview
Table 147. Fresenius Kabi AG Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Fresenius Kabi AG Viral Gastroenteritis Drugs Product
Table 149. Fresenius Kabi AG Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Viral Gastroenteritis Drugs Distributors List
Table 153. Viral Gastroenteritis Drugs Customers List
Table 154. Viral Gastroenteritis Drugs Market Trends
Table 155. Viral Gastroenteritis Drugs Market Drivers
Table 156. Viral Gastroenteritis Drugs Market Challenges
Table 157. Viral Gastroenteritis Drugs Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Viral Gastroenteritis Drugs
Figure 2. Global Viral Gastroenteritis Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Viral Gastroenteritis Drugs Market Share by Type in 2022 & 2029
Figure 4. Antibiotic Product Picture
Figure 5. Antacids Product Picture
Figure 6. Antikinetic Agent Product Picture
Figure 7. Other Product Picture
Figure 8. Global Viral Gastroenteritis Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Viral Gastroenteritis Drugs Market Share by Application in 2022 & 2029
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Other
Figure 13. Global Viral Gastroenteritis Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Viral Gastroenteritis Drugs Market Size (2018-2029) & (US$ Million)
Figure 15. Global Viral Gastroenteritis Drugs Sales (2018-2029) & (K Units)
Figure 16. Global Viral Gastroenteritis Drugs Average Price (US$/Unit) & (2018-2029)
Figure 17. Viral Gastroenteritis Drugs Report Years Considered
Figure 18. Viral Gastroenteritis Drugs Sales Share by Manufacturers in 2022
Figure 19. Global Viral Gastroenteritis Drugs Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Viral Gastroenteritis Drugs Players: Market Share by Revenue in 2022
Figure 21. Viral Gastroenteritis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Viral Gastroenteritis Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Viral Gastroenteritis Drugs Sales Market Share by Country (2018-2029)
Figure 24. North America Viral Gastroenteritis Drugs Revenue Market Share by Country (2018-2029)
Figure 25. United States Viral Gastroenteritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Viral Gastroenteritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Viral Gastroenteritis Drugs Sales Market Share by Country (2018-2029)
Figure 28. Europe Viral Gastroenteritis Drugs Revenue Market Share by Country (2018-2029)
Figure 29. Germany Viral Gastroenteritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Viral Gastroenteritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Viral Gastroenteritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Viral Gastroenteritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Viral Gastroenteritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Viral Gastroenteritis Drugs Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Viral Gastroenteritis Drugs Revenue Market Share by Region (2018-2029)
Figure 36. China Viral Gastroenteritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Viral Gastroenteritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Viral Gastroenteritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Viral Gastroenteritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Viral Gastroenteritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan Viral Gastroenteritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Southeast Asia Viral Gastroenteritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Viral Gastroenteritis Drugs Sales Market Share by Country (2018-2029)
Figure 44. Latin America Viral Gastroenteritis Drugs Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Viral Gastroenteritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Viral Gastroenteritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Viral Gastroenteritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Viral Gastroenteritis Drugs Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Viral Gastroenteritis Drugs Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Viral Gastroenteritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Viral Gastroenteritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Viral Gastroenteritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Viral Gastroenteritis Drugs by Type (2018-2029)
Figure 54. Global Revenue Market Share of Viral Gastroenteritis Drugs by Type (2018-2029)
Figure 55. Global Viral Gastroenteritis Drugs Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Viral Gastroenteritis Drugs by Application (2018-2029)
Figure 57. Global Revenue Market Share of Viral Gastroenteritis Drugs by Application (2018-2029)
Figure 58. Global Viral Gastroenteritis Drugs Price (US$/Unit) by Application (2018-2029)
Figure 59. Viral Gastroenteritis Drugs Value Chain
Figure 60. Viral Gastroenteritis Drugs Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed